A novel industrial monosaccharide, anhydrous-fructose (AF), is produced from starch by a new bio catalytic process using glean liase. Screening, in vitro evolution and rational ensue design will be used to produce glean liase with high performance in the industrial bioconversion of starch to AF. In a concerted action the market potential of AF compound will be exploited by systematic enzymatic and chemical modification of this compound to produce a line of high-value added products, and to study its benefits on human health. One can envisage the production of AF both as bulk product and as fine chemical dependent on its application in chemical synthesis, for therapy and as food ingredient. Commercialisation of AF and derivatives thereof is envisaged by traditional and start-up bio industries that participate in this Tran disciplinary project.
Funding SchemeCSC - Cost-sharing contracts